First Tracks Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Net Income | -50,484 | -47,196 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -32,578 | -45,041 |
Cash | 248,469 | |
Basic Shares | 34,748 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -178,704 | -116,085 |
EBIT | -181,101 | -118,461 |
Net Income | -163,705 | -106,150 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -126,164 | -93,811 |
Cash | 123,080 | 35,965 |
Basic Shares | 34,748 | 34,748 |